Last updated: August 12, 2021
Sponsor: Baskent University
Overall Status: Active - Not Recruiting
Phase
N/A
Condition
Dementia
Treatment
N/AClinical Study ID
NCT05000476
GulsenK
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Age ≥ 18
- The expected duration of stay in the intensive care unit is more than 24 hours.
- In the first 24 hours of hospitalization,
- On mechanical ventilation, conscious patients
- Patients who volunteered to participate in the study
- Not using sleeping pills* * Prescription drugs (benzodiazepines, nonbenzodiazepines),quetiapine, antihistamines, antidepressants used for their sedative effects
Exclusion
Exclusion Criteria:
- illness
- Suspected or approved drug or alcohol poisoning
- Contraindication to the use of earplugs or eye masks (eg facial trauma or other safetyconcerns)
- Patients using hearing aids
- Severe neurological deficits defined as coma (Richmond Agitation Sedation Score <-4 or -5 (deeply sedated and coma) due to cranial trauma, malignancy, anoxic brain injury,or cerebral edema)
- Having a known cognitive disorder (such as dementia, Alzheimer's, psychosis.)
- Patients with a Glasgow coma scale (GCS) of 8 and below
Study Design
Total Participants: 60
Study Start date:
February 21, 2020
Estimated Completion Date:
September 21, 2021
Study Description
Connect with a study center
Baskent University
Ankara, 06790
TurkeySite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.